Bluejay Diagnostics (BJDX) Change in Cash (2020 - 2026)

Bluejay Diagnostics (BJDX) has 7 years of Change in Cash data on file, last reported at -$1.5 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Cash fell 24.84% year-over-year to -$1.5 million; the trailing twelve-month figure through Mar 2026 stood at $568354.0 (up 24.93% YoY), and the FY2025 full-year result was $862930.0, down 58.78% from the prior year.
• Change in Cash eased to -$1.5 million in Q1 2026, from $2.1 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $5.4 million in Q2 2024 to a low of -$3.3 million in Q1 2023.
• A 5-year average of -$903724.8 and a median of -$1.5 million in 2026 frame the typical range for Change in Cash.
• Peak annual rise in Change in Cash reached 420.98% in 2024, while the deepest fall reached 9711.14% in 2024.
• Tracing BJDX's Change in Cash over 5 years: stood at -$3.2 million in 2022, then increased by 9.64% to -$2.9 million in 2023, then soared by 49.32% to -$1.5 million in 2024, then soared by 243.25% to $2.1 million in 2025, then plunged by 171.08% to -$1.5 million in 2026.
• Business Quant data shows BJDX's Change in Cash at -$1.5 million in Q1 2026, $2.1 million in Q4 2025, and -$1.4 million in Q3 2025.